New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Transoral resection of pharyngeal cancer: Summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia
Transoral resection of pharyngeal cancer: Summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK Adelstein, D. J., Ridge, J. A., Brizel, D. M., Holsinger, F. C., Haughey, B. H., O'Sullivan, B., Genden, E. M., Beitler, J. J., Weinstein, G. S., Quon, H., Chepeha, D. B., Ferris, R. L., Weber, R. S., Movsas, B., Waldron, J., Lowe, V., Ramsey, S., Manola, J., Yueh, B., Carey, T. E., Bekelman, J. E., Konski, A. A., Moore, E., Forastiere, A., Schuller, D. E., Lynn, J., Ullmann, C. D. 2012; 34 (12): 1681-1703Abstract
Recent advances now permit resection of many pharyngeal tumors through the open mouth, an approach that can greatly reduce the morbidity of surgical exposure. These transoral techniques are being rapidly adopted by the surgical community and hold considerable promise. On November 6-7, 2011, the National Cancer Institute sponsored a Clinical Trials Planning Meeting to address how to further investigate the use of transoral surgery, both in the good prognosis human papillomavirus (HPV)-initiated oropharyngeal cancers, and in those with HPV-unrelated disease. The proceedings of this meeting are summarized.
View details for DOI 10.1002/hed.23136
View details for Web of Science ID 000311291900001
View details for PubMedID 23015475